ClinicalTrials.Veeva

Menu
I

ICTRIALS Pesquisa e Desenvolvimento | Curitiba, Brazil

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lenalidomide
Obinutuzumab
Ribociclib
Inavolisib
Mosunetuzumab
Tocilizumab
ABBV-399
Sacituzumab
Bendamustine
Telisotuzumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 6 total trials

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) (TroFuse-031)

Researchers are looking for new ways to treat locally advanced or metastatic urothelial cancer (UC). Current treatments for locally advanced or metas...

Enrolling
Bladder Cancer
Drug: Rescue medications for chemotherapy
Drug: Rescue medications for sacituzumab tirumotecan

A study to evaluate the efficacy and safety of triplet combination of inavolisib plus ribociclib and fulvestrant versus placebo plus ribociclib and f...

Enrolling
Breast Cancer
Drug: Inavolisib
Drug: Ribociclib

This study will evaluate the efficacy and safety of mosunetuzumab in combination with lenalidomide (M + Len) compared to rituximab in combination wit...

Active, not recruiting
Relapsed or Refractory Follicular Lymphoma
Drug: Lenalidomide
Drug: Rituximab
Locations recently updated

The purpose of this study is to assess the efficacy and safety of opevesostat plus daily corticosteroids compared to alternative abiraterone acetate...

Enrolling
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Prostatic Neoplasms
Drug: Fludrocortisone acetate
Drug: Abiraterone acetate
Locations recently updated

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor,...

Enrolling
c-MET
Non-Small Cell Lung Cancer
Drug: Telisotuzumab Vedotin

The purpose of this study is to evaluate the efficacy of glofitamab monotherapy compared with an investigator's choice of either rituximab plus benda...

Enrolling
Lymphoma
Drug: Glofitamab
Drug: Rituximab

Trial sponsors

Roche logo
Merck Sharp & Dohme (MSD) logo
AbbVie logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems